A detailed history of Jefferies Financial Group Inc. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 13,000 shares of EBS stock, worth $115,309. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,000
Holding current value
$115,309
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.72 - $14.77 $74,360 - $192,010
13,000 New
13,000 $108,000
Q3 2023

Nov 14, 2023

BUY
$3.17 - $7.91 $13,314 - $33,222
4,200 Added 7.0%
64,200 $218,000
Q2 2023

Aug 14, 2023

BUY
$7.35 - $13.21 $441,000 - $792,600
60,000 New
60,000 $441,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $442M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.